Literature DB >> 17429568

7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.

Eduardo A Perez1, Leonidas G Koniaris, Sarah E Snell, Juan C Gutierrez, William E Sumner, David J Lee, Nicole C Hodgson, Alan S Livingstone, Dido Franceschi.   

Abstract

INTRODUCTION: The aim of the study was to determine outcomes for respiratory and gastrointestinal carcinoid tumors utilizing a large cancer registry.
METHODS: Cases of respiratory and gastrointestinal carcinoid from the Florida Cancer Data System (FCDS) from 1981 to 2001 were reviewed. Descriptive statistics, age-adjusted tumor incidence, and survival rates were determined.
RESULTS: A total of 7201 cases of malignant carcinoid were identified. Pulmonary and gastrointestinal carcinoid tumors comprised 82% of all carcinoids encountered. The mean age was 64.4 +/- 0.15 years. Stratified by location, there were 3000 (51.4%) foregut carcinoids (including those found in the respiratory tree-2325 in the lung), 2130 (36.5%) midgut carcinoids, and 712 (12.2%) hindgut carcinoids. Second, distinct malignancies were observed in 23% of cases. The total age-adjusted incidence rate has increased from 0.62 per 100,000 in 1980 to 5.17 per 100,000 in 2000. Overall median survival was 21.97 months. The median survival was 19.0 months for foregut carcinoids (excluding those arising in the respiratory tract); 33.9 months for midgut tumors; and 22.7 months for hindgut carcinoids. There was a statistically significant better survival for those with midgut tumors than for those in the other groups (P < 0.001). Age < 60 years, white race, and female sex were all associated with better survival (P < 0.01).
CONCLUSIONS: The incidence of pulmonary and gastrointestinal carcinoids has dramatically increased since 1981. Tumor location and age > or = 60 years are the strongest predictors of mortality.

Entities:  

Mesh:

Year:  2007        PMID: 17429568     DOI: 10.1007/s00268-005-0774-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  Rectal carcinoids: the most frequent carcinoid tumor.

Authors:  A B Jetmore; J E Ray; J B Gathright; K M McMullen; T C Hicks; A E Timmcke
Journal:  Dis Colon Rectum       Date:  1992-08       Impact factor: 4.585

Review 2.  Management of midgut carcinoids.

Authors:  Göran Akerström; Per Hellman; Ola Hessman; Liliana Osmak
Journal:  J Surg Oncol       Date:  2005-03-01       Impact factor: 3.454

3.  Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden.

Authors:  K Hemminki; X Li
Journal:  Cancer       Date:  2001-10-15       Impact factor: 6.860

4.  Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.

Authors:  P F Quaedvlieg; O Visser; C B Lamers; M L Janssen-Heijen; B G Taal
Journal:  Ann Oncol       Date:  2001-09       Impact factor: 32.976

5.  Risk of second cancers in patients with colorectal carcinoids.

Authors:  David S Tichansky; Burt Cagir; Edward Borrazzo; Allan Topham; Juan Palazzo; Eric J Weaver; Andrea Lange; Robert D Fry
Journal:  Dis Colon Rectum       Date:  2002-01       Impact factor: 4.585

6.  Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.

Authors:  Weijing Sun; Stuart Lipsitz; Paul Catalano; James A Mailliard; Daniel G Haller
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

7.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

Review 8.  Carcinoid tumour of the appendix.

Authors:  A C Goede; M E Caplin; M C Winslet
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

9.  The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies.

Authors:  J T Gerstle; G L Kauffman; W A Koltun
Journal:  J Am Coll Surg       Date:  1995-04       Impact factor: 6.113

10.  Surgery for carcinoid tumours of the lower gastrointestinal tract.

Authors:  A C Goede; M C Winslet
Journal:  Colorectal Dis       Date:  2003-03       Impact factor: 3.788

View more
  20 in total

1.  Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival.

Authors:  Relin Yang; Michael C Cheung; Felipe E Pedroso; Margaret M Byrne; Leonidas G Koniaris; Teresa A Zimmers
Journal:  J Surg Res       Date:  2011-05-23       Impact factor: 2.192

2.  Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States.

Authors:  Damien J LaPar; Castigliano M Bhamidipati; David A Harris; Benjamin D Kozower; David R Jones; Irving L Kron; Gorav Ailawadi; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-06-25       Impact factor: 4.330

3.  Epidemiology of small bowel carcinoids in a defined population.

Authors:  Kalle Landerholm; Sture Falkmer; Johannes Järhult
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

4.  90Y-edotreotide for metastatic carcinoid refractory to octreotide.

Authors:  David L Bushnell; Thomas M O'Dorisio; M Sue O'Dorisio; Yusuf Menda; Rodney J Hicks; Eric Van Cutsem; Jean-Louis Baulieu; Francoise Borson-Chazot; Lowell Anthony; Al B Benson; Kjell Oberg; Ashley B Grossman; Mary Connolly; Hakim Bouterfa; Yong Li; Katherine A Kacena; Norman LaFrance; Stanislas A Pauwels
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

5.  Secondary malignancy in patients with sporadic neuroendocrine neoplasia.

Authors:  M Krausch; A Raffel; M Anlauf; M Schott; N Lehwald; A Krieg; F Kröpil; K Cupisti; W T Knoefel
Journal:  Endocrine       Date:  2013-03-14       Impact factor: 3.633

6.  Multifocality in Small Bowel Neuroendocrine Tumors.

Authors:  Alexandra Gangi; Emily Siegel; Galinos Barmparas; Simon Lo; Laith H Jamil; Andrew Hendifar; Nicholas N Nissen; Edward M Wolin; Farin Amersi
Journal:  J Gastrointest Surg       Date:  2017-11-08       Impact factor: 3.452

7.  "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.

Authors:  Markus Krausch; Andreas Raffel; Martin Anlauf; Matthias Schott; Nadja Lehwald; Andreas Krieg; Stefan Andreas Topp; Kenko Cupisti; Wolfram Trudo Knoefel
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

8.  Laparoscopic resection of primary midgut carcinoid tumors.

Authors:  Petachia Reissman; Shmail Shmailov; Simona Grozinsky-Glasberg; David J Gross
Journal:  Surg Endosc       Date:  2013-04-10       Impact factor: 4.584

9.  Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.

Authors:  Hans Scherübl; Brigitte Streller; Roland Stabenow; Hermann Herbst; Michael Höpfner; Christoph Schwertner; Joachim Steinberg; Jan Eick; Wanda Ring; Krishna Tiwari; Sören M Zappe
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

10.  Defining the role of surgery for primary gastrointestinal tract melanoma.

Authors:  Michael C Cheung; Eduardo A Perez; Manuel A Molina; Xiaoling Jin; Juan C Gutierrez; Dido Franceschi; Alan S Livingstone; Leonidas G Koniaris
Journal:  J Gastrointest Surg       Date:  2007-12-05       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.